Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app hopes to help teens with cancer beat fatigue

NCT ID NCT07274358

Symptom relief Sponsor: Koç University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a mobile app called HopeMove designed to help teenagers with cancer stay physically active and reduce fatigue. Fifteen adolescents aged 13 to 18 who were receiving cancer treatment used the app for four weeks, doing guided exercises at least three times a week. Researchers measured how usable and satisfying the app was, and whether it helped with fatigue. This was a small pilot study to see if the idea is feasible before larger trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HopeMove mobile application
What this could lead to
If this app proves helpful, it could offer a simple, low-cost way for teens with cancer to reduce fatigue and stay active during treatment.
What could go wrong
This is a very small pilot study with only 15 participants and no comparison group. The app may not work for everyone, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Aug 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * adolescents aged 13-18 years * receiving active hematology-oncology treatment * able to use a smartphone running Android operating system * has internet access * voluntarily agrees to participate * parent/guardian consent obtained (if applicable) * able to perform light-moderate exercise * able to complete at least 75% of planned exercise sessions Exclusion Criteria: * having a chronic illness requiring regular invasive procedures, * having received analgesics within the past 2 hours, * having experienced a seizure within the past 2 hours, * using antiepileptic medication, * having a body temperature above 37.5°C * not having parental consent, * being agitated at the time of the procedure, * having any auditory or visual impairments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer Fatigue Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mobile application Physical activity

Contacts and locations

Locations

  • Istanbul University

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.